Personalis Inc (PSNL)
5.52
+0.52
(+10.40%)
USD |
NASDAQ |
Nov 05, 14:54
Personalis Gross Profit Margin (Quarterly): 35.59% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 35.59% |
March 31, 2024 | 28.13% |
December 31, 2023 | 26.45% |
September 30, 2023 | 19.08% |
June 30, 2023 | 28.70% |
March 31, 2023 | 25.08% |
December 31, 2022 | 13.83% |
September 30, 2022 | 16.68% |
June 30, 2022 | 23.47% |
March 31, 2022 | 28.09% |
December 31, 2021 | 38.66% |
September 30, 2021 | 36.23% |
June 30, 2021 | 37.69% |
Date | Value |
---|---|
March 31, 2021 | 35.57% |
December 31, 2020 | 30.09% |
September 30, 2020 | 26.91% |
June 30, 2020 | 23.97% |
March 31, 2020 | 21.08% |
December 31, 2019 | 36.16% |
September 30, 2019 | 32.82% |
June 30, 2019 | 37.30% |
March 31, 2019 | 28.31% |
December 31, 2018 | 36.70% |
September 30, 2018 | 38.45% |
June 30, 2018 | 27.23% |
March 31, 2018 | 2.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
13.83%
Minimum
Dec 2022
38.66%
Maximum
Dec 2021
27.97%
Average
28.09%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
Repligen Corp | 49.82% |
Myriad Genetics Inc | 69.55% |
Axogen Inc | 73.77% |
CareDx Inc | 69.71% |
Perspective Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -59.05% |
Return on Assets | -37.66% |
Return on Invested Capital | -58.47% |
Profit Margin (Quarterly) | -56.70% |
Operating Margin (Quarterly) | -74.81% |
Return on Net Operating Assets | -84.56% |